Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention (Q44211302)
Jump to navigation
Jump to search
scientific article published in November 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention |
scientific article published in November 2002 |
Statements
1 reference
Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention (English)
1 reference
Sandeep Khosla
1 reference
Binu Kunjummen
1 reference
Mayra Guerrero
1 reference
Ravi Manda
1 reference
Mansoor Razminia
1 reference
Atul Trivedi
1 reference
Vasundhara Vidyarthi
1 reference
Monther Elbazour
1 reference
Aziz Ahmed
1 reference
David Lubell
1 reference
1 November 2002
1 reference
1 reference
9
1 reference
6
1 reference
488-491
1 reference
Identifiers
1 reference
1 reference